| Literature DB >> 32501448 |
Ji Wang1, Weimin Zhou1, Hua Ling2, Xiaoping Dong1, Yi Zhang1, Jiandong Li1, Yong Zhang1, Jingdong Song1, William J Liu1, Yang Li1, Ruiqing Zhang1,3, Wei Zhen1, Kun Cai1, Shuangli Zhu1, Dongyan Wang1, Jinbo Xiao1, Yigang Tong4, Wenli Liu4, Lihua Song4, Wei Wu1, Yang Liu1, Xiang Zhao1, Ruihuan Wang1,5, Sheng Ye2, Jing Wang6, Roujian Lu1, Baoying Huang1, Fei Ye1, Wenwen Lei1, Rongbao Gao1, Qi Shi1, Cao Chen1, Jun Han1, Wenbo Xu1, George F Gao1, Xuejun Ma1,7, Guizhen Wu1.
Abstract
Here, we report the identification of Histoplasma causing an unexplained disease cluster in Matthews Ridge, Guyana. In March 2019, 14 employees of Chongqing Bosai Mining Company, China, working in a manganese mining of Guyana, had unexplained fever, and two of them died. We obtained lung and brain tissues as well as the blood samples from the two deceased cases (patient No. 1 and 2), and bronchoscopy lavages and cerebrospinal fluid samples from one severe case (patient No. 3), respectively. All samples were tested by pathological examination, high-throughput sequencing, and real-time PCR. Pathological detection showed the presence of spore-like structures in the lung tissue of patient No. 1, indicating a fungal infection in this patient. Nanopore sequencing identified the existing of H. capsulatum in the lung tissue sample within 13 h. Next-generation sequencing identified specific fragments of H. capsulatum in all of the samples tested (lung, brain and blood serum from the deceased cases, and plasma from the severe case). Real-time PCR assays did not reveal any viral infection related to transmission from bat feces. We conclude that H. capsulatum was the causative pathogen of this disease cluster based on epidemiologic, clinical, pathological and nucleic acid evidence.Entities:
Keywords: Fever; Histochemical examination; Histoplasma; Nanopore high-throughput sequencing; Real-time PCR
Year: 2019 PMID: 32501448 PMCID: PMC7148593 DOI: 10.1016/j.bsheal.2019.12.003
Source DB: PubMed Journal: Biosaf Health
Figure 1Strategy and workflow of pathogen identification.
Basic demographic data of the patients involved in this epidemic.
| Patient No. | Age | Sample types |
|---|---|---|
| 1 | 46 | Lung tissue (autopsy) |
| 2 | 44 | Brain tissue (autopsy), serum |
| 3 | 42 | Plasma, bronchoscopy lavages, cerebrospinal fluid (severe, but survived) |
| 4 | 50 | Blood, nasopharyngeal swabs |
| 5 | 32 | Blood, nasopharyngeal swabs |
| 6 | 43 | Blood, nasopharyngeal swabs |
| 7 | 50 | Blood, nasopharyngeal swabs |
| 8 | 48 | Blood, nasopharyngeal swabs |
| 9 | 56 | Blood, nasopharyngeal swabs |
| 10 | 30 | Blood, nasopharyngeal swabs |
| 11 | 40 | Blood, nasopharyngeal swabs |
| 12 | 47 | Blood, nasopharyngeal swabs |
Figure 3Periodic acid-Schiff staining of the lung tissue from patient No. 1 (deceased). The arrow indicates a spore-like structure.
Figure 4Aligned result of a typical nanopore sequencing read obtained from the lung tissue of patient No. 1.
Figure 5Aligned result of typical PGM sequencing read obtained from plasma from patient No. 3.